Rifampicin increases the extent of P2Y12 receptor blockade achieved by clopidogrel administration

被引：0
|
作者：
Patil, S. B. G. [1 ]
Judge, H. M. [1 ]
Buckland, R. J. [1 ]
Jakubowski, J. A. [2 ]
Storey, R. F. [1 ]
机构：
[1] Univ Sheffield, Cardiovasc Res Unit, Sheffield, S Yorkshire, England
[2] Lilly Res Labs, Res, Indianapolis, IN USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC-MO-012
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [41] P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
    Jorgensen, Niklas R.
    Schwarz, Peter
    Iversen, Helle K.
    Vestergaard, Peter
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [42] P2Y12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement
    Matsushita, Kensuke
    Marchandot, Benjamin
    Kibler, Marion
    Heger, Joe
    Peillex, Marilou
    Trimaille, Antonin
    Hess, Sebastien
    Grunebaum, Lelia
    Ohana, Mickael
    Reydel, Antje
    Jesel, Laurence
    Ohlmann, Patrick
    Morel, Olivier
    CIRCULATION, 2019, 140
  • [43] Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockade
    Kuliczkowski, Wiktor
    Rychlik, Blazej
    Chizynski, Krzysztof
    Watala, Cezary
    Golanski, Jacek
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (04): : 115 - 120
  • [44] P2Y12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement
    Matsushita, Kensuke
    Marchandot, Benjamin
    Kibler, Marion
    Trimaille, Antonin
    Hess, Sebastien
    Grunebaum, Lelia
    Reydel, Antje
    Jesel, Laurence
    Ohlmann, Patrick
    Morel, Olivier
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (21) : 2707 - 2708
  • [45] Importance of potent P2Y12 receptor blockade in acute myocardial infarction: focus on prasugrel
    Jeong, Young-Hoon
    Tantry, Udaya S.
    Gurbel, Paul A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (12) : 1771 - 1796
  • [46] The P2Y12 receptor: no active metabolite, no party
    Carlo Patrono
    Nature Reviews Cardiology, 2009, 6 : 271 - 272
  • [47] The P2Y12 receptor as a target of antithrombotic drugs
    O'Connor, Stephen
    Montalescot, Gilles
    Collet, Jean-Philippe
    PURINERGIC SIGNALLING, 2011, 7 (03) : 325 - 332
  • [48] Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade Are Two Better Than One?
    Vaduganathan, Muthiah
    Bhatt, Deepak L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (03) : 427 - 428
  • [49] The Function and Regulation of Platelet P2Y12 Receptor
    Li, Xiaohua
    Zhang, Guoxing
    Cao, Xia
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 199 - 216
  • [50] P2Y12 RECEPTOR AS A THERAPEUTIC TARGET IN SEPSIS
    Liverani, E.
    Rico, M. C.
    Kunapuli, S. P.
    Kilpatrick, L.
    SHOCK, 2015, 43 (06): : 82 - 83
12345